Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
about
Systematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent ImmunizationsEarly direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic reviewPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisPractice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic ReviewEvaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort StudyHigh HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial.Development and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents.Human papillomavirus vaccination: the population impact.Human papilloma virus vaccination: impact and recommendations across the world.Towards the eradication of HPV infection through universal specific vaccination.Educational interventions to increase HPV vaccination acceptance: a systematic review.Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.Parents' views on human papillomavirus vaccination for sexually transmissible infection prevention: a qualitative studyEvaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan AfricaMapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria.Serological test results of sexually transmitted diseases in patients with condyloma acuminataParents' Recall and Reflections on Experiences Related to HPV Vaccination for Their Children.Human Papillomavirus Vaccine Initiation among 9-13-Year-Olds in the United States.Mothers' willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study.Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes.Impact of HPV vaccination on anogenital warts and respiratory papillomatosisHuman papillomavirus and oropharyngeal cancer in Greenland in 1994-2010.Ten years of anti-HPV vaccinations: what do we know?Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.Diverse Families' Experiences with HPV Vaccine Information Sources: A Community-Based Participatory Approach.The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland.The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.Including boys in the human papillomavirus (HPV) vaccination programme.Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system.Reduction in the burden of hospital admissions due to cervical disease from 2003-2014 in Spain.The Impact of Human Papillomavirus Catch-Up Vaccination in Australia: Implications for Introduction of Multiple Age Cohort Vaccination and Postvaccination Data Interpretation.Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.
P2860
Q28078812-79C48E95-B28B-4AE6-BDE1-953648913E39Q28081927-FB59C232-A4A1-453A-9E59-9B719F62B848Q28084924-DB68884C-AB8F-4E8E-AE2E-B40DCDA9D0EAQ28262413-D0C74F8A-69C3-448A-89BE-1016D4F00982Q28647510-011F73BD-CBD7-4BBF-8E3A-AF7021AA4A2CQ30206108-DC09DFB2-9BEA-416F-8D72-14E96CAE87E2Q33645571-E1C397F5-E77C-4866-B2D2-3D737B8343A3Q33806566-EF156017-566A-4669-9CE9-1ACF29E03B03Q34704575-D67D3434-DEEC-4209-81A4-219EDA0D3396Q34812959-C29CC152-43A3-4495-8B05-11481DD6C215Q34846745-04B7CB7A-594E-466B-AFB1-87ADBF5F8C6BQ35088687-5F644E34-4BAB-47E7-9055-37617942BB96Q35221196-C4720DAD-89B4-4B90-8A49-EA4AF3133DA6Q35790310-C0DB7596-9ED5-4BD5-B196-7DFC03949CDCQ35887646-3626A7AD-DDA6-4F91-AFA7-39186C8D575FQ35888255-E12B98BA-C671-4ED7-BDA8-970BEA3B212DQ35991580-11D8AFA7-CAD0-44AF-AB65-B58B1D6B2E76Q36048456-1D3D6413-7A3A-44D8-A537-03698643B300Q36069114-ADAF1BBD-AB02-4AAB-9CB3-316F803B1476Q36298355-468549B2-1D3A-4F19-9CA0-2F91C7C51719Q36976107-AC03F407-EECA-4978-97EB-C3F107546349Q37130168-9F57EA05-424C-44E0-B045-51A14AC47C01Q37284313-17B0A8EB-A8BC-47D6-A805-03955976FBF4Q37289348-5BA97858-09E1-4DED-B594-26D3AF786856Q37473145-F8DF9BDE-CBA5-4A4D-A38F-4DE29794C800Q38399052-4CCB58F4-67A1-44EA-B896-AD78C73542BAQ38804622-BE266AAD-7E24-4DEE-A2B6-344E626A42ADQ39297199-2812B7B4-2945-40DB-B0DB-C25A96C79575Q41437184-38542033-AC01-4D33-AB05-DE26BE1CBFB7Q41923803-1FCA4CF4-BB3C-40A4-B5D0-D6386BE73297Q42231856-8653463A-8956-46F3-8064-1009FCBF7EE4Q47280272-1A7638CD-A817-442F-98A4-48E0391E5215Q47367286-DF67EC9D-F115-409A-8873-9A883F0AE6ACQ47625999-18B7506A-255C-43C9-95E8-54F50473F5B9Q49206271-5026EAB3-A589-4485-9B35-01E68718ECFAQ55261252-0C9CAF82-E4CD-4D4F-BFBC-84740AC27DA6
P2860
Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Significant decrease in the in ...... lomavirus vaccination program.
@en
Significant decrease in the in ...... lomavirus vaccination program.
@nl
type
label
Significant decrease in the in ...... lomavirus vaccination program.
@en
Significant decrease in the in ...... lomavirus vaccination program.
@nl
prefLabel
Significant decrease in the in ...... lomavirus vaccination program.
@en
Significant decrease in the in ...... lomavirus vaccination program.
@nl
P2093
P50
P1476
Significant decrease in the in ...... llomavirus vaccination program
@en
P2093
Carsten Sand
Klaus K Andersen
Louise Baandrup
P304
P356
10.1097/OLQ.0B013E31827BD66B
P577
2013-02-01T00:00:00Z